258 related articles for article (PubMed ID: 19506550)
1. S100A4 mediates endometrial cancer invasion and is a target of TGF-beta1 signaling.
Xie R; Schlumbrecht MP; Shipley GL; Xie S; Bassett RL; Broaddus RR
Lab Invest; 2009 Aug; 89(8):937-47. PubMed ID: 19506550
[TBL] [Abstract][Full Text] [Related]
2. Blocking TGF-β inhibits breast cancer cell invasiveness via ERK/S100A4 signal.
Wang XG; Meng Q; Qi FM; Yang QF
Eur Rev Med Pharmacol Sci; 2014; 18(24):3844-53. PubMed ID: 25555875
[TBL] [Abstract][Full Text] [Related]
3. Hypomethylation-induced expression of S100A4 in endometrial carcinoma.
Xie R; Loose DS; Shipley GL; Xie S; Bassett RL; Broaddus RR
Mod Pathol; 2007 Oct; 20(10):1045-54. PubMed ID: 17673926
[TBL] [Abstract][Full Text] [Related]
4. Functional interaction between Smad3 and S100A4 (metastatin-1) for TGF-beta-mediated cancer cell invasiveness.
Matsuura I; Lai CY; Chiang KN
Biochem J; 2010 Feb; 426(3):327-35. PubMed ID: 20070253
[TBL] [Abstract][Full Text] [Related]
5. S100A4 silencing suppresses proliferation, angiogenesis and invasion of thyroid cancer cells through downregulation of MMP-9 and VEGF.
Jia W; Gao XJ; Zhang ZD; Yang ZX; Zhang G
Eur Rev Med Pharmacol Sci; 2013 Jun; 17(11):1495-508. PubMed ID: 23771538
[TBL] [Abstract][Full Text] [Related]
6. CCNs, fibulin-1C and S100A4 expression in leiomyoma and myometrium: inverse association with TGF-beta and regulation by TGF-beta in leiomyoma and myometrial smooth muscle cells.
Luo X; Ding L; Chegini N
Mol Hum Reprod; 2006 Apr; 12(4):245-56. PubMed ID: 16571622
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia upregulates ovarian cancer invasiveness via the binding of HIF-1α to a hypoxia-induced, methylation-free hypoxia response element of S100A4 gene.
Horiuchi A; Hayashi T; Kikuchi N; Hayashi A; Fuseya C; Shiozawa T; Konishi I
Int J Cancer; 2012 Oct; 131(8):1755-67. PubMed ID: 22287060
[TBL] [Abstract][Full Text] [Related]
8. S100A4 expression is increased in stricture fibroblasts from patients with fibrostenosing Crohn's disease and promotes intestinal fibroblast migration.
Cunningham MF; Docherty NG; Burke JP; O'Connell PR
Am J Physiol Gastrointest Liver Physiol; 2010 Aug; 299(2):G457-66. PubMed ID: 20489045
[TBL] [Abstract][Full Text] [Related]
9. Estrogen‑related receptor γ promotes the migration and metastasis of endometrial cancer cells by targeting S100A4.
Hua T; Wang X; Chi S; Liu Y; Feng D; Zhao Y; Wang H
Oncol Rep; 2018 Aug; 40(2):823-832. PubMed ID: 29901152
[TBL] [Abstract][Full Text] [Related]
10. S100A4 regulates motility and invasiveness of human esophageal squamous cell carcinoma through modulating the AKT/Slug signal pathway.
Zhang K; Zhang M; Zhao H; Yan B; Zhang D; Liang J
Dis Esophagus; 2012; 25(8):731-9. PubMed ID: 22458600
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA LOC285194 inhibits proliferation and migration but promoted apoptosis in vascular smooth muscle cells via targeting miR-211/PUMA and TGF-β1/S100A4 signal.
Wang S; Li P; Jiang G; Guan J; Chen D; Zhang X
Bioengineered; 2020 Dec; 11(1):718-728. PubMed ID: 32619136
[TBL] [Abstract][Full Text] [Related]
12. RAGE Mediates the Pro-Migratory Response of Extracellular S100A4 in Human Thyroid Cancer Cells.
Medapati MR; Dahlmann M; Ghavami S; Pathak KA; Lucman L; Klonisch T; Hoang-Vu C; Stein U; Hombach-Klonisch S
Thyroid; 2015 May; 25(5):514-27. PubMed ID: 25744544
[TBL] [Abstract][Full Text] [Related]
13. S100A4 regulates migration and invasion in hepatocellular carcinoma HepG2 cells via NF-κB-dependent MMP-9 signal.
Zhang J; Zhang DL; Jiao XL; Dong Q
Eur Rev Med Pharmacol Sci; 2013 Sep; 17(17):2372-82. PubMed ID: 24065232
[TBL] [Abstract][Full Text] [Related]
14. RAGE mediates S100A4-induced cell motility via MAPK/ERK and hypoxia signaling and is a prognostic biomarker for human colorectal cancer metastasis.
Dahlmann M; Okhrimenko A; Marcinkowski P; Osterland M; Herrmann P; Smith J; Heizmann CW; Schlag PM; Stein U
Oncotarget; 2014 May; 5(10):3220-33. PubMed ID: 24952599
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
Parekh TV; Gama P; Wen X; Demopoulos R; Munger JS; Carcangiu ML; Reiss M; Gold LI
Cancer Res; 2002 May; 62(10):2778-90. PubMed ID: 12019154
[TBL] [Abstract][Full Text] [Related]
16. S100A4 amplifies TGF-β-induced fibroblast activation in systemic sclerosis.
Tomcik M; Palumbo-Zerr K; Zerr P; Avouac J; Dees C; Sumova B; Distler A; Beyer C; Cerezo LA; Becvar R; Distler O; Grigorian M; Schett G; Senolt L; Distler JH
Ann Rheum Dis; 2015 Sep; 74(9):1748-55. PubMed ID: 24709861
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of AKT3 Increases Migration and Metastasis in Triple Negative Breast Cancer Cells by Upregulating S100A4.
Grottke A; Ewald F; Lange T; Nörz D; Herzberger C; Bach J; Grabinski N; Gräser L; Höppner F; Nashan B; Schumacher U; Jücker M
PLoS One; 2016; 11(1):e0146370. PubMed ID: 26741489
[TBL] [Abstract][Full Text] [Related]
18. Relaxin enhances in-vitro invasiveness of breast cancer cell lines by upregulation of S100A4/MMPs signaling.
Cao WH; Liu HM; Liu X; Li JG; Liang J; Liu M; Niu ZH
Eur Rev Med Pharmacol Sci; 2013 Mar; 17(5):609-17. PubMed ID: 23543443
[TBL] [Abstract][Full Text] [Related]
19. S100A4 promotes pancreatic cancer progression through a dual signaling pathway mediated by Src and focal adhesion kinase.
Che P; Yang Y; Han X; Hu M; Sellers JC; Londono-Joshi AI; Cai GQ; Buchsbaum DJ; Christein JD; Tang Q; Chen D; Li Q; Grizzle WE; Lu YY; Ding Q
Sci Rep; 2015 Feb; 5():8453. PubMed ID: 25677816
[TBL] [Abstract][Full Text] [Related]
20. RNA interference suppression of A100A4 reduces the growth and metastatic phenotype of human renal cancer cells via NF-kB-dependent MMP-2 and bcl-2 pathway.
Yang XC; Wang X; Luo L; Dong DH; Yu QC; Wang XS; Zhao K
Eur Rev Med Pharmacol Sci; 2013 Jun; 17(12):1669-80. PubMed ID: 23832737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]